{
    "organizations": [],
    "uuid": "9cdff39604935a75ca47cbcb42166c43500de033",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-neurovive-decides-on-a-rights-issu/brief-neurovive-decides-on-a-rights-issue-for-continued-drug-development-idUSFWN1Q50F4",
    "ord_in_thread": 0,
    "title": "BRIEF-Neurovive Decides On A Rights Issue For Continued Drug Development",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 15 (Reuters) - NEUROVIVE PHARMACEUTICAL AB:\n* NEUROVIVE DECIDES ON A RIGHTS ISSUE FOR CONTINUED DRUG DEVELOPMENT\n* ‍TO ISSUE SHARES AND WARRANTS WITH PREFERENTIAL RIGHTS FOR EXISTING SHAREHOLDERS (“RIGHTS ISSUE”)​\n* ‍UPON FULL SUBSCRIPTION TO RIGHTS ISSUE, CO WILL RECEIVE ABOUT MSEK 78.5 BEFORE ISSUANCE COSTS.​\n* ‍IN FULL EXERCISE OF WARRANTS ISSUED IN RIGHTS ISSUE, CO WILL RECEIVE AN ADDITIONAL MSEK 37.3 BEFORE ISSUANCE COSTS.​\n* ‍SUBSCRIPTION PRICE IS SEK 8 PER UNIT, CORRESPONDING TO SEK 2 PER SHARE.​\n* ‍SUBSCRIPTION PERIOD RUNS FROM 10 APRIL - 24 APRIL 2018.​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-02-15T15:43:00.000+02:00",
    "crawled": "2018-02-16T16:53:05.011+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "neurovive",
        "pharmaceutical",
        "ab",
        "neurovive",
        "decides",
        "right",
        "issue",
        "continued",
        "drug",
        "development",
        "issue",
        "share",
        "warrant",
        "preferential",
        "right",
        "existing",
        "shareholder",
        "right",
        "issue",
        "full",
        "subscription",
        "right",
        "issue",
        "co",
        "receive",
        "msek",
        "issuance",
        "full",
        "exercise",
        "warrant",
        "issued",
        "right",
        "issue",
        "co",
        "receive",
        "additional",
        "msek",
        "issuance",
        "price",
        "sek",
        "per",
        "unit",
        "corresponding",
        "sek",
        "per",
        "period",
        "run",
        "april",
        "april",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}